SRNE Overview
Upcoming Projects (SRNE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SRNE)
-
Discussing SP-102 (SEMDEXA) for the treatment of Lumbar Radicular Pain
Ticker: SRNE
Executed On: Feb 04, 2022 at 09:30 AM EST
Upcoming & Overdue Catalysts (SRNE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SRNE)
-
Sorrento Announces Positive Data from a Combined Phase 2 & 3 Clinical Study of STI-004, an Anti-IgE Biosimilar Antibody
Ticker: SRNE
Occurred on: May 16, 2016
Strategic Initiatives (SRNE)
-
Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline
Tickers: SRNE, Semnur
Announcement Date: Aug 15, 2016
